logo
  • 首页
  • 学术期刊
  • 论文检测
  • AIGC检测
  • 热点
  • 更多
    • 数据

Ipilimumab/nivolumabLack of efficacy and autoimmune colitis: 2 case reports

被引:0
|
作者:
机构:
来源:
Reactions Weekly | 2024年 / 2035卷 / 1期
关键词:
D O I:
10.1007/s40278-024-71002-2
中图分类号:
学科分类号:
摘要:
引用
收藏
页码:252 / 252
相关论文
共 50 条
  • [21] Ipilimumab/NivolumabLack of efficacy: case report
    Reactions Weekly, 2024, 2039 (1) : 282 - 282
  • [22] Ipilimumab and nivolumabLack of efficacy
    Reactions Weekly, 2024, 1998 (1) : 278 - 278
  • [23] Ipilimumab/nivolumabLack of efficacy and enterocolitis: case report
    Reactions Weekly, 2020, 1817 (1) : 182 - 182
  • [24] Ipilimumab/nivolumabLack of efficacy and myositis: case report
    Reactions Weekly, 2023, 1957 (1) : 313 - 313
  • [25] Infliximab/Ipilimumab/NivolumabLack of efficacy: case report
    Reactions Weekly, 2025, 2040 (1) : 470 - 470
  • [26] Ipilimumab/nivolumabLack of efficacy
    Reactions Weekly, 2024, 2015 (1) : 212 - 212
  • [27] Denosumab/ipilimumab/nivolumabLack of efficacy: case report
    Reactions Weekly, 2023, 1961 (1) : 155 - 155
  • [28] Atezolizumab/Bevacizumab/NivolumabLack of efficacy: 2 case reports
    Reactions Weekly, 2025, 2040 (1) : 129 - 129
  • [29] NivolumabLack of efficacy: 5 case reports
    Reactions Weekly, 2023, 1963 (1) : 426 - 426
  • [30] Ipilimumab/nivolumabHepatitis and colitis: 2 case reports
    Reactions Weekly, 2020, 1829 (1) : 223 - 223
← 12345 →